FDB Unveils Advanced AI Solutions for Health Workflows
In a significant step toward enhancing healthcare automation, FDB (First Databank, Inc.) recently announced its latest technological advancements aimed at optimizing medication workflows. With the HIMSS26 Global Health Conference and Exhibition on the horizon, FDB is excited to showcase its pioneering solutions designed to empower healthcare organizations with trusted medication intelligence.
FDB MedProof MCP: Redefining Medication Safety
At the forefront of these innovations is the FDB MedProof MCP™, a Model Context Protocol server that acts as a foundation for connecting agentic systems to standardized medication knowledge. This advanced technology facilitates a seamless integration of AI-driven applications within clinical settings, ensuring that healthcare providers can deliver safe and efficient patient care.
The introduction of the MedProof MCP server has sparked immediate interest, with numerous organizations rapidly adopting this AI-native solution. President David Delaney emphasized the importance of this tool, stating, “Healthcare organizations are moving quickly to adopt new AI-driven assistance and automation capabilities, but medication workflows demand a higher standard of safety and accountability.”
As more healthcare providers recognize the potential of MedProof MCP, FDB positions itself as a leader in integrating AI in medication workflows, confidently bridging the gap between technology and essential clinical practices.
Innovative AI Agents: Transforming Prescription Processes
Alongside MedProof MCP, FDB is also rolling out two distinctive intelligent solutions: FDB Script Agent™ and FDB VerifyAssist™. The Script Agent is specifically designed for ambulatory care settings, where the efficiency of prescription processes is paramount. By automating the entry of structured prescription orders based on clinician-patient interactions, this AI agent aims to save valuable clinician time and enhance patient care.
In practice, providers using the Script Agent anticipate a reduction of documentation time by 70%. This efficiency not only allows clinicians to dedicate more time toward patient care but also boosts workflow efficiency across healthcare settings. The Script Agent integrates seamlessly with electronic health records (EHR), showcasing FDB's commitment to reducing operational burdens in clinical environments.
Enhancing Medication Verification with VerifyAssist
Another critical component introduced by FDB is VerifyAssist. This AI-powered assistant streamlines the medication order verification process, which traditionally consumes 30%-40% of a pharmacist's time. VerifyAssist automates the identification of essential verification criteria relevant to each patient's clinical data during the verification phase.
This automation efficiently supports pharmacists by reducing the cognitive load and minimizing unnecessary navigation through patient charts, thereby aligning clinical workflows with regulatory compliance and safety standards.
Looking Ahead to HIMSS26
As HIMSS26 approaches, FDB is poised to highlight these groundbreaking innovations—MedProof MCP, Script Agent, and VerifyAssist—demonstrating how they can integrate to enhance medication safety and clinician experiences. Virginia Halsey, SVP of strategy and product management at FDB, noted, “These advancements represent the next phase of FDB's evolution, moving beyond data delivery to more intelligent, workflow-integrated solutions.”
HIMSS26 will provide a platform for FDB to share its vision for the future of clinical intelligence and automation. Attendees are encouraged to visit FDB at Booth #3235 to learn more about how these cutting-edge solutions can transform medication workflows and support better health outcomes.
About FDB
Founded with a commitment to delivering clinically robust and actionable drug knowledge, FDB continuously works to enhance patient safety and improve healthcare operations. The company's innovative solutions are trusted in healthcare systems used by hospitals, pharmacies, and clinics, thus impacting millions daily. For further information, visit
FDB's website.
In conclusion, FDB's recent advancements signify a promising future for healthcare automation, focusing on safety, efficiency, and improved patient outcomes. As the industry prepares for HIMSS26, these groundbreaking solutions are set to redefine medication management and workflow integration across various healthcare environments.